标题
Foxp3 expression in T regulatory cells and other cell lineages
作者
关键词
Foxp3, T cells, Tumor, Epithelial cells, Macrophages
出版物
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 63, Issue 9, Pages 869-876
出版商
Springer Nature
发表日期
2014-07-25
DOI
10.1007/s00262-014-1581-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cutting Edge: Broad Expression of the FoxP3 Locus in Epithelial Cells: A Caution against Early Interpretation of Fatal Inflammatory Diseases following In Vivo Depletion of FoxP3-Expressing Cells
- (2014) G.-Y. Chen et al. JOURNAL OF IMMUNOLOGY
- FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast
- (2013) Aseem Lal et al. BREAST CANCER RESEARCH AND TREATMENT
- Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?
- (2013) Theresa L. Whiteside CANCER IMMUNOLOGY IMMUNOTHERAPY
- FOXP3 Regulates Sensitivity of Cancer Cells to Irradiation by Transcriptional Repression of BRCA1
- (2013) W. Li et al. CANCER RESEARCH
- Negligible Nuclear FOXP3 Expression in Breast Cancer Epithelial Cells Compared With FOXP3-Positive T Cells
- (2013) Raoul A. Droeser et al. Clinical Breast Cancer
- Development and Maintenance of Regulatory T cells
- (2013) Naganari Ohkura et al. IMMUNITY
- Investigations on the clinical significance of FOXP3 protein expression in cervical oesophageal cancer and the number of FOXP3+ tumour-infiltrating lymphocytes
- (2013) Ming Xia et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Tissues in Different Anatomical Sites Can Sculpt and Vary the Tumor Microenvironment to Affect Responses to Therapy
- (2013) Christel Devaud et al. MOLECULAR THERAPY
- Inhibition of p300 impairs Foxp3+ T regulatory cell function and promotes antitumor immunity
- (2013) Yujie Liu et al. NATURE MEDICINE
- Immunologic Targeting of FOXP3 in Inflammatory Breast Cancer Cells
- (2013) Smita Nair et al. PLoS One
- Induced CD4+Foxp3+ Regulatory T Cells in Immune Tolerance
- (2012) Angelina M. Bilate et al. Annual Review of Immunology
- TNFα induced FOXP3–NFκB interaction dampens the tumor suppressor role of FOXP3 in gastric cancer cells
- (2012) Qiang Hao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Lack of Foxp3+ macrophages in both untreated and B16 melanoma-bearing mice
- (2012) C. T. Mayer et al. BLOOD
- Macrophages have no lineage history of Foxp3 expression
- (2012) S. Put et al. BLOOD
- Expression of Forkhead box P3 in tumour cells causes immunoregulatory function of signet ring cell carcinoma of the stomach
- (2012) M Yoshii et al. BRITISH JOURNAL OF CANCER
- FOXP3 expression in tumor cells and implications for cancer progression
- (2012) Tiziana Triulzi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Autofluorescence contributes to false-positive intracellular Foxp3 staining in macrophages: A lesson learned from flow cytometry
- (2012) Fuqiang Li et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Depleting regulatory T cells with arginine-rich, cell-penetrating, peptide-conjugated morpholino oligomer targeting FOXP3 inhibits regulatory T-cell function
- (2011) M A Morse et al. CANCER GENE THERAPY
- CD8+Foxp3+ T cells share developmental and phenotypic features with classical CD4+Foxp3+ regulatory T cells but lack potent suppressive activity
- (2011) Christian T. Mayer et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Regulatory T cells and Foxp3
- (2011) Alexander Y. Rudensky IMMUNOLOGICAL REVIEWS
- Rapamycin Combined with TGF- Converts Human Invariant NKT Cells into Suppressive Foxp3+ Regulatory Cells
- (2011) L. Moreira-Teixeira et al. JOURNAL OF IMMUNOLOGY
- FOXP3 and FOXP3-regulated microRNAs suppress SATB1 in breast cancer cells
- (2011) N McInnes et al. ONCOGENE
- Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy
- (2010) Sylvain Ladoire et al. BREAST CANCER RESEARCH AND TREATMENT
- Histone acetyltransferase mediated regulation of FOXP3 acetylation and Treg function
- (2010) Yan Xiao et al. CURRENT OPINION IN IMMUNOLOGY
- A Peptide Inhibitor of FOXP3 Impairs Regulatory T Cell Activity and Improves Vaccine Efficacy in Mice
- (2010) N. Casares et al. JOURNAL OF IMMUNOLOGY
- Identification of Regulatory Foxp3+ Invariant NKT Cells Induced by TGF-
- (2010) M. Monteiro et al. JOURNAL OF IMMUNOLOGY
- Somatic Single Hits Inactivate the X-Linked Tumor Suppressor FOXP3 in the Prostate
- (2009) Lizhong Wang et al. CANCER CELL
- Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
- (2009) Makoto Miyara et al. IMMUNITY
- FOXP3 Expression and Overall Survival in Breast Cancer
- (2009) Andrea Merlo et al. JOURNAL OF CLINICAL ONCOLOGY
- Cutting Edge: Depletion of Foxp3+ Cells Leads to Induction of Autoimmunity by Specific Ablation of Regulatory T Cells in Genetically Targeted Mice
- (2009) J. Kim et al. JOURNAL OF IMMUNOLOGY
- Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control TH2 responses
- (2009) Ye Zheng et al. NATURE
- The Regulatory T Cell-Associated Transcription Factor FoxP3 Is Expressed by Tumor Cells
- (2008) L. M. Ebert et al. CANCER RESEARCH
- Regulatory T Cells and Immune Tolerance
- (2008) Shimon Sakaguchi et al. CELL
- Generation of highly suppressive adaptive CD8+CD25+FOXP3+ regulatory T cells by continuous antigen stimulation
- (2008) Milada Mahic et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Foxp3 expression in human cancer cells
- (2008) Vaios Karanikas et al. Journal of Translational Medicine
- TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function
- (2008) Liang Zhou et al. NATURE
- Regulatory T Cells: Mechanisms of Differentiation and Function
- (2007) Steven Z. Josefowicz et al. Annual Review of Immunology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started